COCP - Cocrystal Pharma to Present at the H.C. Wainwright 6th Annual Israel Conference
– Live video webcast with the Cocrystal management team, on Thursday, November 12 th at 12:00 PM EST –
BOTHELL, WA, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that the Cocrystal management team, will present at the H.C. Wainwright 6 th Annual Israel Conference on Thursday, November 12, 2020 at 12:00 PM EST.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference.
A live video webcast of the presentation will be available on the IR Calendar page of the Investors section of the Company’s website ( cocrystalpharma.com ). The video webcast replay will be made available two hours following the event.
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, SARS-CoV-2 virus, hepatitis C viruses, and norovirus. Cocrystal employs unique, proprietary, structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com .
Investor and Media Contact:
JTC Team, LLC
(833) 475-8247
COCP@jtcir.com
###